{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:23:46Z","timestamp":1788279826139,"version":"build-2803163510"},"reference-count":104,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jaad.2019.01.072","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:45:24Z","timestamp":1549327524000},"page":"228-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus"],"prefix":"10.1016","volume":"81","author":[{"given":"Dimitrios","family":"Rigopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumiya","family":"Chiheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Carlton Ralph","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilton","family":"Di Chiacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatis","family":"Gregoriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chander","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckart","family":"Haneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Iorizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Pasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Maria","family":"Piraccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Richert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Rompoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam I.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Starace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Triantafyllopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zaiac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jaad.2019.01.072_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000316179","article-title":"Treatment and management of psoriasis with nail involvement: a focus on biologic therapy","volume":"221","author":"Langley","year":"2010","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.072_bib2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000246274","article-title":"Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients","volume":"193","author":"de Jong","year":"1996","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/archderm.1969.01610230059011","article-title":"Psoriasis of the nail. A clinical-pathologic study","volume":"99","author":"Zaias","year":"1969","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","article-title":"Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy","volume":"57","author":"Jiaravuthisan","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2019.01.072_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000316169","article-title":"The burden of nail psoriasis: an introduction","volume":"221","author":"Baran","year":"2010","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ad.2011.02.007","article-title":"Nail psoriasis in individuals with psoriasis vulgaris: a study of 661 patients [in Spanish]","volume":"102","author":"Armesto","year":"2011","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/bjd.12354","article-title":"Nail psoriasis: a questionnaire-based survey","volume":"169","author":"Klaassen","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.01.072_bib8","series-title":"Baran and Dawber's Diseases of the Nails and their Management","first-page":"257","article-title":"The nail in dermatological disease","author":"Holzberg","year":"2012"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.072_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10227-002-0143-0","article-title":"Psoriatic nails: a prospective clinical study","volume":"7","author":"Salomon","year":"2003","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2133.2010.09831.x","article-title":"Nail psoriasis in Germany: epidemiology and burden of disease","volume":"163","author":"Augustin","year":"2010","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2019.01.072_bib11","doi-asserted-by":"crossref","first-page":"i71","DOI":"10.1136\/ard.2010.144097","article-title":"The early phase of psoriatic arthritis","volume":"70","author":"McGonagle","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2017.04.001","article-title":"Nail findings in patients with psoriatic arthritis: a cross-sectional study with special reference to transverse grooves","volume":"77","author":"Zenke","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaad.2013.02.009","article-title":"Fingernail psoriasis reconsidered: a case-control study","volume":"69","author":"van der Velden","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.072_bib14","first-page":"482","article-title":"Clinical observations on nail changes in psoriasis","volume":"17","author":"Tham","year":"1988","journal-title":"Ann Acad Med Singapore"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.072_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000335571","article-title":"Linear pitting and splinter haemorrhages are more commonly seen in the nails of patients with established psoriasis in comparison to psoriatic arthritis","volume":"223","author":"Palmou","year":"2011","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib16","first-page":"165","article-title":"Nail changes in psoriasis\u2013a profile","volume":"21","author":"Puri","year":"2011","journal-title":"J Pak Assoc Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2340\/00015555-0195","article-title":"Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study","volume":"87","author":"Rigopoulos","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.072_bib18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2133.1998.02462.x","article-title":"Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid","volume":"139","author":"Tosti","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.01.072_bib19","series-title":"Nail Disorders","author":"Tosti","year":"2018"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2133.1998.02031.x","article-title":"A simplified protocol of steroid injection for psoriatic nail dystrophy","volume":"138","author":"de Berker","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.01.072_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archderm.1962.01590100033009","article-title":"Psoriasis and lichen planus of nalis. Treatment with triamcinolone","volume":"86","author":"Gerstein","year":"1962","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2019.01.072_bib22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1346-8138.2005.tb00882.x","article-title":"Efficacy of triamcinolone acetonide in various acquired nail dystrophies","volume":"32","author":"Grover","year":"2005","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.072_bib23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ced.13087","article-title":"Role of nail bed methotrexate injections in isolated nail psoriasis: conventional drug via an unconventional route","volume":"42","author":"Daulatabad","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.clindermatol.2013.06.012","article-title":"Nail surgery","volume":"31","author":"Haneke","year":"2013","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1529-8019.2007.00113.x","article-title":"Nail surgery: practical tips and treatment options","volume":"20","author":"Jellinek","year":"2007","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib26","first-page":"351","article-title":"Efficacy of digital anesthesia: comparison of two techniques","volume":"6","author":"Ahmad","year":"2017","journal-title":"World J Plast Surg"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.072_bib27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhsa.2014.01.017","article-title":"Comparison of local anesthetics for digital nerve blocks: a systematic review","volume":"39","author":"Vinycomb","year":"2014","journal-title":"J Hand Surg"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/J.JHSB.2006.06.001","article-title":"A comparison of traditional digital blocks and single subcutaneous palmar injection blocks at the base of the finger and a meta-analysis of the digital block trials","volume":"31","author":"Yin","year":"2006","journal-title":"J Hand Surg Br"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2019.01.072_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2009.03363.x","article-title":"Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease","volume":"23","author":"McGonagle","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib30","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1365-2133.2008.09023.x","article-title":"Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis","volume":"160","author":"Reich","year":"2009","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.01.072_bib31","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/rheumatology\/keh198","article-title":"Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked","volume":"43","author":"Williamson","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-3083.2009.03344.x","article-title":"Development and validation of nail psoriasis quality of life scale (NPQ10)","volume":"24","author":"Ortonne","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/S0190-9622(03)00910-1","article-title":"Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis","volume":"49","author":"Rich","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bjd.12664","article-title":"Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes","volume":"170","author":"Augustin","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib35","first-page":"123","article-title":"The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis","volume":"34","author":"Cassell","year":"2007","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.01.072_bib36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaad.2014.02.010","article-title":"Scoring nail psoriasis","volume":"70","author":"Klaassen","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/09546630903085328","article-title":"Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectations","volume":"21","author":"Uhlenhake","year":"2010","journal-title":"J Dermatol Treat"},{"issue":"6","key":"10.1016\/j.jaad.2019.01.072_bib38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40265-016-0564-5","article-title":"Nail psoriasis: a review of treatment options","volume":"76","author":"Pasch","year":"2016","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/myc.12542","article-title":"Onychomycosis in patients with nail psoriasis: a point to point discussion","volume":"60","author":"Rigopoulos","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2019.01.072_bib40","first-page":"1","article-title":"A randomized comparison of efficacy and safety of intralesional triamcinolone injection and clobetasol propionate ointment for psoriatic nails","author":"Boontaveeyuwat","year":"2018","journal-title":"J Dermatol Treat"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.1973.tb02956.x","article-title":"Intradermal triamcinolone treatment of nail dystrophies","volume":"89","author":"Abell","year":"1973","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2133.1974.tb06724.x","article-title":"Intralesional triamcinolone acetonide using the Port-O-Jet and needle injections in localized dermatoses","volume":"91","author":"Bleeker","year":"1974","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2133.1976.tb15536.x","article-title":"The treatment of psoriatic nail dystrophy with intradermal steroid injections","volume":"95","author":"Peachey","year":"1976","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib44","first-page":"78","article-title":"Treatment of nail psoriasis with a modified regimen of steroid injections","volume":"18","author":"Saleem","year":"2008","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2310\/7750.2013.13078","article-title":"Treatment of nail psoriasis with intralesional triamcinolone acetonide using a needle-free jet injector: a prospective trial","volume":"18","author":"Nantel-Battista","year":"2014","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00015550252948220","article-title":"Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream","volume":"82","author":"Rigopoulos","year":"2002","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib47","first-page":"279","article-title":"Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis","volume":"88","author":"Tzung","year":"2008","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.072_bib48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000202179","article-title":"Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment","volume":"218","author":"Rigopoulos","year":"2009","journal-title":"Dermatology"},{"issue":"8","key":"10.1016\/j.jaad.2019.01.072_bib49","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1468-3083.2008.02679.x","article-title":"Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment","volume":"22","author":"S\u00e1nchez Rega\u00f1a","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1684\/ejd.2017.3173","article-title":"Treatment of nail psoriasis with topical application of clobetasol propionate 0.05% solution: a pilot study","volume":"28","author":"Brandi","year":"2018","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib51","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/09546630902787585","article-title":"Tacalcitol ointment for the treatment of nail psoriasis","volume":"20","author":"M\u00e1rquez Balb\u00e1s","year":"2009","journal-title":"J Dermatol Treat"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib52","first-page":"355","article-title":"Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study","volume":"68","author":"Scher","year":"2001","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2133.2003.05392.x","article-title":"Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study","volume":"149","author":"Bianchi","year":"2003","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2019.01.072_bib54","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ad.2012.04.008","article-title":"Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment","volume":"103","author":"Fischer-Levancini","year":"2012","journal-title":"Actas Dermosifiliogr"},{"issue":"8","key":"10.1016\/j.jaad.2019.01.072_bib55","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1468-3083.2012.04642.x","article-title":"Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study","volume":"27","author":"De Simone","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.01.072_bib56","first-page":"51","article-title":"Nail psoriasis: clinical features, pathogenesis, differential diagnoses, and management","volume":"7","author":"Haneke","year":"2017","journal-title":"Psoriasis (Auckl)"},{"issue":"8","key":"10.1016\/j.jaad.2019.01.072_bib57","first-page":"912","article-title":"A randomized, double-blinded trial evaluating the efficacy and tolerability of vectical ointment (calcitriol 3 mcg\/g ointment) when compared to betamethasone diproprionate ointment (64 mg\/g) in patients with nail psoriasis","volume":"13","author":"Kole","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib58","first-page":"5","article-title":"Topical calcipotriol therapy in nail psoriasis: a study of 24 cases","volume":"11","author":"Zakeri","year":"2005","journal-title":"Dermatol Online J"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1590\/S0365-05962012000200003","article-title":"Comparison of nail lacquer clobetasol efficacy at 0.05%, 1% and 8% in nail psoriasis treatment: prospective, controlled and randomized pilot study","volume":"87","author":"Nakamura","year":"2012","journal-title":"An Bras Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib60","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.1987.91660010035013","article-title":"Distal phalangeal atrophy secondary to topical steroid therapy","volume":"123","author":"Deffer","year":"1987","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/archdermatol.2008.600","article-title":"Evaluation of the efficacy of acitretin therapy for nail psoriasis","volume":"145","author":"Tosti","year":"2009","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2019.01.072_bib62","first-page":"1039","article-title":"Effectiveness of systemic treatment agents on psoriatic nails: a comparative study","volume":"12","author":"Demirsoy","year":"2013","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib63","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1468-3083.2010.03938.x","article-title":"Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy)","volume":"25","author":"S\u00e1nchez-Rega\u00f1a","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib64","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1529-8019.2012.01539.x","article-title":"Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result","volume":"26","author":"Ricceri","year":"2013","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib65","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/120347540400800208","article-title":"Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol","volume":"8","author":"Feliciani","year":"2004","journal-title":"J Cutan Med Surg"},{"issue":"6","key":"10.1016\/j.jaad.2019.01.072_bib66","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2133.1993.tb03350.x","article-title":"Response of nail psoriasis to cyclosporin","volume":"129","author":"Arnold","year":"1993","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib67","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0190-9622(95)90189-2","article-title":"Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement","volume":"32","author":"Mahrle","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib68","first-page":"248","article-title":"Successful treatment of psoriatic nails with low-dose cyclosporine administration","volume":"17","author":"Syuto","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2019.01.072_bib69","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3899\/jrheum.110242","article-title":"Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial","volume":"38","author":"Karanikolas","year":"2011","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.jaad.2019.01.072_bib70","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1468-3083.2010.03927.x","article-title":"Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study","volume":"25","author":"G\u00fcm\u00fc\u015fel","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"17","key":"10.1016\/j.jaad.2019.01.072_bib71","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1010858","article-title":"A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis","volume":"365","author":"Reich","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jaad.2019.01.072_bib72","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/jdv.13354","article-title":"European S3-guidelines on the systemic treatment of psoriasis vulgaris--update 2015--short version--EDF in cooperation with EADV and IPC","volume":"29","author":"Nast","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.jaad.2019.01.072_bib74","first-page":"1065","article-title":"A 36-week retrospective open trial comparing the efficacy of biological therapies in nail psoriasis","volume":"11","author":"Bardazzi","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib75","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jaad.2007.07.042","article-title":"Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year","volume":"58","author":"Rich","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib76","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2133.2008.08686.x","article-title":"Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study","volume":"159","author":"Rigopoulos","year":"2008","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib77","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1468-3083.2010.03826.x","article-title":"Infliximab efficacy in nail psoriasis. A retrospective study in 48 patients","volume":"25","author":"Fabroni","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib78","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000317775","article-title":"Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial","volume":"221","author":"Reich","year":"2010","journal-title":"Dermatology"},{"issue":"9","key":"10.1016\/j.jaad.2019.01.072_bib79","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/1346-8138.12229","article-title":"Treatment of nail psoriasis with tumor necrosis factor-alpha blocker agents: an open-label, unblinded, comparative study","volume":"40","author":"Ozmen","year":"2013","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.072_bib80","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1517\/14712598.2013.736960","article-title":"TNF-\u03b1 antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis","volume":"13","author":"Saraceno","year":"2013","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib81","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/bjd.12060","article-title":"A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis","volume":"168","author":"Ortonne","year":"2013","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2019.01.072_bib82","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1468-3083.2009.03211.x","article-title":"Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis","volume":"23","author":"Luger","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib83","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/ar3054","article-title":"Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy","volume":"12","author":"Rudwaleit","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib84","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/ard.2009.111856","article-title":"Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions","volume":"69","author":"Van den Bosch","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.072_bib85","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1468-3083.2009.03453.x","article-title":"Treatment of nail psoriasis with adalimumab: an open label unblinded study","volume":"24","author":"Rigopoulos","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib86","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/jdv.12553","article-title":"Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study","volume":"29","author":"Tha\u00e7i","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.jaad.2019.01.072_bib87","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/jdv.12198","article-title":"Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and\/or feet: post hoc analysis of REACH","volume":"28","author":"Poulin","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib88","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaad.2017.08.029","article-title":"Adalimumab for nail psoriasis: efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial","volume":"78","author":"Elewski","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.072_bib89","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/art.24403","article-title":"Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four-week efficacy and safety results of a randomized, placebo-controlled study","volume":"60","author":"Kavanaugh","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.072_bib90","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/bjd.12632","article-title":"Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1","volume":"170","author":"Rich","year":"2014","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib91","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1346-8138.2011.01347.x","article-title":"Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: long-term results from a phase 2\/3 clinical trial","volume":"39","author":"Igarashi","year":"2012","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.072_bib92","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000334482","article-title":"Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study","volume":"223","author":"Rigopoulos","year":"2011","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib93","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-4632.2011.05320.x","article-title":"Ustekinumab for the treatment of nail psoriasis in heavily treated psoriatic patients","volume":"52","author":"Vitiello","year":"2013","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2019.01.072_bib94","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/archdermatol.2010.332","article-title":"Ustekinumab for rapid treatment of nail psoriasis","volume":"146","author":"Rallis","year":"2010","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2019.01.072_bib95","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/jdv.12359","article-title":"Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial","volume":"28","author":"Paul","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jaad.2019.01.072_bib96","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jdv.12996","article-title":"Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis","volume":"29","author":"Langley","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jaad.2019.01.072_bib97","first-page":"958","article-title":"Ixekizumab is effective in subjects with moderate to severe plaque psoriasis with significant nail involvement: results from UNCOVER 3","volume":"15","author":"Dennehy","year":"2016","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib98","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/jdv.14033","article-title":"Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3","volume":"31","author":"van de Kerkhof","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib99","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaad.2015.09.001","article-title":"Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)","volume":"74","author":"Rich","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaad.2017.01.053","article-title":"Efficacy of tofacitinib for the treatment of nail psoriasis: two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis","volume":"77","author":"Merola","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2019.01.072_bib101","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/1346-8138.13956","article-title":"Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: subgroup analyses from a randomized, placebo-controlled phase 3 trial","volume":"44","author":"Abe","year":"2017","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.072_bib102","doi-asserted-by":"crossref","first-page":"e000582","DOI":"10.1136\/rmdopen-2017-000582","article-title":"4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis","volume":"4","author":"van der Heijde","year":"2018","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib103","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaad.2016.11.041","volume":"76","author":"Blauvelt","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.072_bib104","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaad.2016.11.042","volume":"76","author":"Reich","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.01.072_bib105","article-title":"Effect of secukinumab on clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial","author":"Reich","year":"2018","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219301835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219301835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:50:33Z","timestamp":1759272633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219301835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0190962219301835"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.072","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}